Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-02-10

Clinical Trial Update: Pharmacokinetic-pharmacodynamic Analysis of Sugammadex for Conventional Reversal in Children [Phase 2]

View source ↗

Summary

Phase 2 trial assessing pharmacokinetic-pharmacodynamic analysis of sugammadex for conventional reversal in children has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Sugammadex (sugammadex)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Anesthesia, General, Neuromuscular Blockade | Phase 2 | Status: COMPLETED